Clinical Trial Update: Fampridine Pregnancy Exposure Registry

View source ↗

Summary

Biogen has terminated the Fampridine Pregnancy Exposure Registry, a study tracking pregnancy outcomes in people with multiple sclerosis treated with dalfampridi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine (4-aminopyridine)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis, Pregnancy | Status: TERMINATED